Physician profile
Danielle C Murray
NPI 1831617414
$1,838.13
in general payments reported to CMS, 2019-2025
17 companies · $516 in 2025
The $516 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $486 · 2024: $836 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502 · Education: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.16 |
| Education | $335.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $597.77 | 2023-2025 | Ilumya |
| Janssen Biotech, INC. | $348.50 | 2023-2025 | Tremfya, Stelara, Simponi |
| Genzyme Corporation | $242.65 | 2023-2024 | |
| Abbvie INC. | $87.30 | 2023-2025 | |
| Ucb, INC. | $70.67 | 2024-2025 | Bimzelx |
| Galderma Laboratories, L.P. | $69.08 | 2024-2025 | Nemluvio, Aklief, Oracea |
| E.R. Squibb & Sons, L.L.C. | $62.73 | 2024-2025 | Sotyktu |
| Verrica Pharmaceuticals INC. | $55.05 | 2024 | Ycanth |
| Regeneron Healthcare Solutions, INC. | $51.79 | 2024 | Libtayo |
| Lilly USA, LLC | $47.27 | 2024 | Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $37.18 | 2024 | |
| Paratek Pharmaceuticals, INC. | $35.58 | 2024-2025 | Nuzyra |
| Springworks Therapeutics, INC. | $32.83 | 2025 | Gomekli |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.57 | 2024 | Spevigo, Cyltezo |
| Incyte Corporation | $23.76 | 2025 | Opzelura |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $22.96 | 2025 | Hadlima |
| Amgen INC. | $22.44 | 2024 | Otezla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.